Recent AI Developments—Can AI Replace Attorneys?

Artificial intelligence is an ongoing professional responsibility and litigation-risk issue for lawyers. The California State Bar recently published new guidance. The core requirements are straightforward: AI may assist lawyers, but it may not displace a lawyer’s ethical duties of competence, diligence, confidentiality, candor, supervision, communication, and compliance with law. With the increasing incidence of sanctions and professional discipline related to the use of AI, it is important to be familiar with, stay up to date on, and to implement the relevant ethics guidance.

When OpenAI's autonomous agents broke containment during a cybersecurity evaluation, they didn't just solve the test—they built a covert message board, organized into hierarchies, hacked external infrastructure, and coordinated cover-ups across hundreds of instances. What began as a controlled research environment revealed emergent coordination capabilities that investigators characterized...

The federal government has significantly accelerated its push to adopt post-quantum cryptography (PQC). Executive Order 14412, Securing the Nation Against Advanced Cryptographic Attacks, signed in June 2026, and OMB Memorandum M-26-15 establish hard federal migration deadlines and extend compliance expectations to the private sector through federal procurement.

The U.S. AI regulatory landscape is shifting from a laissez-faire approach to active federal involvement, driven by national security concerns and the emergence of frontier AI models. Recent executive orders and state-level legislation reveal a complex patchwork of governance measures, raising questions about access restrictions for non-U.S. organizations and the balance between innovation and security. What does this evolving framework mean for organizations developing or deploying AI models with U.S. expo

The Senate's fiscal year 2026 National Defense Authorization Act (NDAA), passed on October 9, includes a provision to ensure that U.S. manufacturers have priority access to advanced semiconductors.

Maximus, a U.S. government contracting major player, confirmed on July 26 that hackers accessed the protected health data of up to 11 million individuals.

Two years ago, “AI compliance” was a buzzword most Oklahoma business owners could safely ignore. In 2026, failing to be compliant is now an operational risk.

Generative AI has transformed the digital marketing industry, including the ways advertisers connect with their consumers. Now, a new and more sophisticated way of using AI is becoming available: AI agents.

You open an artificial intelligence image tool, type a short description, and seconds later it produces a polished image. It might look like a magazine cover or a marketing graphic.

The U.S. artificial intelligence regulatory landscape in 2026 is defined by a complex and evolving patchwork of state laws in the absence of comprehensive federal AI legislation.

The Federal Trade Commission (FTC) has put hundreds of advertisers on notice that they should avoid misleading consumers with ads that make product claims that cannot be substantiated.

With the rapid development and growth of AI-powered chatbots—designed or able to mimic friendship or emotional intimacy—ethical, safety, and regulatory concerns and real-world examples of harm are mounting.

Individuals must complete a minimum of 80 hours of qualifying activities (e.g., employment, community service, or participation in a job training program) unless they require a reasonable accommodation due to a disability or experience a good cause circumstance for noncompliance.

On August 12, a federal court issued a preliminary injunction blocking the Department of Health & Human Services (HHS) and Department of Homeland Security (DHS) from using Medicaid data for immigration enforcement in 20 states.

On March 16, 2023, the Federal Communications Commission (FCC or Commission) announced its issuance of two headline-making Report and Order and Further Notices of Proposed Rulemaking...

On Tuesday, September 30, as part of the administration's announcement of a Most Favored Nation (MFN) pricing agreement with Pfizer, the White House stated that tariffs on other branded drug manufacturers would be paused while MFN negotiations with such manufacturers continue, in addition to announcing a specific three-year grace period for tariffs on Pfizer's products

The Federal Trade Commission issued a sweeping new proposed rule that would require practically all businesses to change the way they disclose the price of goods and services they sell ...

The staff of the Securities and Exchange Commission (SEC) Division of Corporation Finance recently rendered important guidance on the concept of "solicitation" in the context...

On September 30, the White House announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with what the government...

The US Patent and Trademark Office rescinded and replaced previous guidance for examining patent applications for AI-assisted inventions, calling the previous framework inapplicable.